T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.

[1]  F. Djouad,et al.  Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. , 2003, Blood.

[2]  P. Rameshwar,et al.  Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens1 , 2003, The Journal of Immunology.

[3]  J. Mosca,et al.  Characterization and functionality of cell surface molecules on human mesenchymal stem cells. , 2003, Journal of biomedical science.

[4]  E. Guinan,et al.  Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation , 2003, Transplantation.

[5]  O. Ringdén,et al.  Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.

[6]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[7]  D. Ganten,et al.  Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning , 2002, Nature Medicine.

[8]  Kevin McIntosh,et al.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.

[9]  J. Tremblay,et al.  COMBINED IMMUNOSUPPRESSION OF MYCOPHENOLATE MOFETIL AND FK506 FOR MYOBLAST TRANSPLANTATION IN mdx MICE1 , 2001, Transplantation.

[10]  M. Pittenger,et al.  Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  Alan W. Flake,et al.  Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep , 2000, Nature Medicine.

[12]  R. Deans,et al.  Mesenchymal stem cells: biology and potential clinical uses. , 2000, Experimental hematology.

[13]  I. Alexander,et al.  Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity. , 1999, Journal of immunology.

[14]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[15]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[16]  M. Mielcarek,et al.  Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. , 1998, Blood.

[17]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[18]  J. Hansen,et al.  Alloantigen Presenting Function of Normal Human CD34+ Hematopoietic Cells , 1996 .

[19]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[20]  C. Anasetti,et al.  Alloantigen presenting function of normal human CD34+ hematopoietic cells. , 1996, Blood.

[21]  M. Battegay,et al.  Fibroblasts as efficient antigen-presenting cells in lymphoid organs. , 1995, Science.

[22]  R. Lechler,et al.  Myoblasts fail to stimulate T cells but induce tolerance. , 1994, International immunology.

[23]  L. Lanier,et al.  B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.

[24]  F. Ruscetti,et al.  Pleiotropic Effects of Transforming Growth Factor‐β on Cells of the Immune System , 1993, Annals of the New York Academy of Sciences.

[25]  J. Donnelly,et al.  A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-gamma. , 1993, Experimental eye research.

[26]  V. Theobald,et al.  “NEUTRAL ALLOGRAFTS”‐LACK OF ALLOGENEIC STIMULATION BY CULTURED HUMAN CELLS EXPRESSING MHC CLASS I AND CLASS II ANTIGENS , 1993, Transplantation.

[27]  Y. Shimabukuro,et al.  Interferon-gamma-dependent immunosuppressive effects of human gingival fibroblasts. , 1992, Immunology.

[28]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[29]  S. Moskalewski,et al.  Effect of immunosuppression on rejection of cartilage formed by transplanted allogeneic rib chondrocytes in mice. , 1991, Clinical orthopaedics and related research.

[30]  G. Burmester,et al.  Antigenicity and accessory cell function of human articular chondrocytes. , 1991, The Journal of rheumatology.

[31]  H. Skjødt,et al.  Human osteoblast-like cells expressing MHC class II determinants stimulate allogeneic and autologous peripheral blood mononuclear cells and function as antigen-presenting cells. , 1989, Immunology.

[32]  T. Gajewski,et al.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. , 1988, Journal of immunology.

[33]  J. Vilček,et al.  Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. , 1987, Journal of immunology.

[34]  A. Friedenstein,et al.  STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES: Cloning In Vitro and Retransplantation In Vivo , 1974, Transplantation.

[35]  B. Sigurdsson.  A specific antigen recovered from tissue infected with M. paratuberculosis (Johne's bacillus) studies on a second, inhibiting substance in the infected mucosa. , 1947, Journal of immunology.